CA2515601C - Mecanisme de soulevement epidermique s'appliquant sur le nez - Google Patents

Info

Publication number

CA2515601C

CA2515601C CA002515601A CA2515601A CA2515601C CA 2515601 C CA2515601 C CA 2515601C CA 002515601 A CA002515601 A CA 002515601A CA 2515601 A CA2515601 A CA 2515601A CA 2515601 C CA2515601 C CA 2515601C

Authority

CA

Canada

Prior art keywords

section

layer

margin

adhesive

nose

Prior art date

1996-05-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 230000007246 mechanism Effects 0.000 title claims abstract description 85
• 239000000463 material Substances 0.000 claims abstract description 110
• 239000000853 adhesive Substances 0.000 claims abstract description 80
• 230000001070 adhesive effect Effects 0.000 claims abstract description 80
• 239000013013 elastic material Substances 0.000 claims description 34
• 239000002648 laminated material Substances 0.000 claims description 9
• 229920000728 polyester Polymers 0.000 claims description 7
• 239000011248 coating agent Substances 0.000 claims description 2
• 238000000576 coating method Methods 0.000 claims description 2
• 239000010410 layer Substances 0.000 description 79
• 210000001331 nose Anatomy 0.000 description 78
• 206010052428 Wound Diseases 0.000 description 69
• 208000027418 Wounds and injury Diseases 0.000 description 69
• 229920000126 latex Polymers 0.000 description 40
• 239000004816 latex Substances 0.000 description 38
• 210000002615 epidermis Anatomy 0.000 description 31
• 238000000034 method Methods 0.000 description 15
• 210000003491 skin Anatomy 0.000 description 14
• 230000009471 action Effects 0.000 description 12
• 230000001965 increasing effect Effects 0.000 description 12
• 238000011282 treatment Methods 0.000 description 12
• 238000004873 anchoring Methods 0.000 description 9
• 239000003814 drug Substances 0.000 description 7
• 239000012528 membrane Substances 0.000 description 7
• 230000006870 function Effects 0.000 description 6
• 239000007789 gas Substances 0.000 description 6
• 230000000087 stabilizing effect Effects 0.000 description 6
• 239000012790 adhesive layer Substances 0.000 description 5
• 238000005452 bending Methods 0.000 description 5
• 239000000084 colloidal system Substances 0.000 description 5
• 230000035876 healing Effects 0.000 description 5
• 229920001296 polysiloxane Polymers 0.000 description 5
• 150000001875 compounds Chemical class 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 238000010276 construction Methods 0.000 description 3
• 230000000774 hypoallergenic effect Effects 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 239000012858 resilient material Substances 0.000 description 3
• 238000010008 shearing Methods 0.000 description 3
• 238000001356 surgical procedure Methods 0.000 description 3
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
• 201000007848 Arts syndrome Diseases 0.000 description 2
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
• 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
• NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 235000010410 calcium alginate Nutrition 0.000 description 2
• 239000000648 calcium alginate Substances 0.000 description 2
• 229960002681 calcium alginate Drugs 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 238000011109 contamination Methods 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 230000010339 dilation Effects 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 230000001815 facial effect Effects 0.000 description 2
• 239000000416 hydrocolloid Substances 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 230000001788 irregular Effects 0.000 description 2
• 229920006267 polyester film Polymers 0.000 description 2
• 229920006264 polyurethane film Polymers 0.000 description 2
• 230000029058 respiratory gaseous exchange Effects 0.000 description 2
• 239000002356 single layer Substances 0.000 description 2
• 235000010413 sodium alginate Nutrition 0.000 description 2
• 239000000661 sodium alginate Substances 0.000 description 2
• 229940005550 sodium alginate Drugs 0.000 description 2
• 230000000007 visual effect Effects 0.000 description 2
• NDKWCCLKSWNDBG-UHFFFAOYSA-N zinc;dioxido(dioxo)chromium Chemical compound [Zn+2].[O-][Cr]([O-])(=O)=O NDKWCCLKSWNDBG-UHFFFAOYSA-N 0.000 description 2
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 239000004775 Tyvek Substances 0.000 description 1
• 229920000690 Tyvek Polymers 0.000 description 1
• 239000003522 acrylic cement Substances 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000002421 anti-septic effect Effects 0.000 description 1
• 235000013532 brandy Nutrition 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 238000009434 installation Methods 0.000 description 1
• JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
• 210000003127 knee Anatomy 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 210000003928 nasal cavity Anatomy 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 230000037081 physical activity Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 238000009827 uniform distribution Methods 0.000 description 1